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Abstract 
Postprandial glycemic responses to meals are inhibited by polyphenol-rich plant 
foods. Combinations of polyphenols may be particularly effective through 
complementary mechanisms. A randomized, controlled, double-blinded cross-over 
trial was conducted in healthy volunteers to test the hypothesis that apple and 
blackcurrant polyphenol-rich drinks would reduce postprandial blood glucose 
concentrations. Secondary outcomes included insulin and glucose-dependent 
insulinotropic polypeptide (GIP) secretion. Twenty men (mean age 26 y, SD 8) and 
5 postmenopausal women (mean age 57 y, SD 3) consumed a placebo drink (CON) 
and 2 polyphenol-rich drinks containing fruit extracts: either 1200 mg apple 
polyphenols (AE), or 600 mg apple polyphenols + 600 mg blackcurrant 
anthocyanins (AE+BE), in random order with a starch and sucrose meal. 
Incremental areas under the curve (iAUC) for plasma glucose concentrations were 
lower following AE+BE over 0-30 and 0-120 min compared with CON; mean 
differences (95% CI) -32 mmol/L·min (-41, -22, P<0.0005) and -52 mmol/L.min (-94, 
-9, P<0.05), respectively. AE significantly reduced iAUC 0-30 min (mean difference 
-26 mmol/L.min, -35, -18, P<0.0005) compared with CON, but the difference over 
120 min was not significant. Postprandial insulin, C-peptide and GIP concentrations 
were significantly reduced relative to CON. A dose response inhibition of glucose 
transport was demonstrated in Caco-2 cells, including total and GLUT-mediated 
transport, and SGLT1-mediated glucose transport was strongly inhibited at all 
doses in Xenopus oocytes, following 10 min incubation with 0.125-4 mg apple 
polyphenols/ml. In conclusion, ingestion of apple and blackcurrant polyphenols 
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decreased postprandial glycemia, which may be partly related to inhibition of 
intestinal glucose transport. 
 
KEYWORDS: randomized controlled trial, postprandial blood glucose, polyphenols, 
insulin, glucose-dependent insulinotropic polypeptide, apple.  
 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
5 
 
5 
 
1. Introduction 
According to the World Health Organization, 9 % of the world’s adult population 
suffers from diabetes, and the rising prevalence of type 2 diabetes (T2D) is predicted 
to reach exceptional levels [1]. Regular exposure to diets with a high glycemic load 
(a measure of the overall blood glucose-raising effect of a serving of a food) may 
contribute to postprandial hyperglycemia, a risk factor for T2D and endothelial 
dysfunction [2, 3, 4, 5]. Strategies to control chronic postprandial hyperglycemia by 
optimizing the functionality of foods would strengthen efforts to reduce the risk of 
developing T2D in the general population. The physico-chemical composition of 
certain fruits, including cell wall structure [6] and polyphenolic constituents [7, 8], 
may help to delay starch and disaccharide digestion and glucose absorption 
following a carbohydrate-containing meal or beverage. In vitro studies suggest that 
some berry anthocyanins and apple polyphenols are effective inhibitors of digestive 
enzymes, α-amylases and α-glucosidases [9, 10, 11, 12, 13]. Furthermore, 
polyphenols found in berries and apples inhibit the action of intestinal glucose 
transporters SGLT1 and GLUT2 [8, 14, 15, 16, 17, 18]. Human data is limited; 
however randomized controlled trials (RCTs) have shown that berries [19, 20, 21, 
22] and apple products [8, 23, 24] reduced postprandial glucose concentrations 
following consumption of either starch, glucose or sucrose loads. However, the 
majority of study designs have administered the whole fruit or fruit product, e.g. juice, 
making it difficult to identify the effects of the polyphenols relative to other aspects of 
the fruit composition. Confounding factors, including the degree of mastication, 
variability in the food matrix, and interactions with macronutrients, could influence the 
release of polyphenols and digestible carbohydrate from plant cell walls in whole fruit 
test meals [25, 26]. A previous RCT showed that a drink containing 600 mg of 
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blackcurrant anthocyanins (1600 mg blackcurrant polyphenols) decreased early 
postprandial glycemia [27] following the consumption of a starch- and sucrose-rich 
meal. The present study tested the hypothesis that consumption of drinks containing 
highly purified polyphenol-rich apple and anthocyanin-rich blackcurrant extracts 
together with a starch and sucrose meal would reduce the extent of the initial 
postprandial glycemic response. The primary outcome variable was early 
postprandial glycemia (incremental area under the curve (iAUC) 0-30 min); 
secondary outcome variables included other measures of postprandial glycemia 
(iAUC 0-120 min, Cmax, Tmax), parameters of plasma insulin secretion (insulin, C-
peptide), incretin response (glucose-dependent insulinotropic polypeptide, GIP), and 
non-esterified fatty acid (NEFA) responses, and markers of vascular function. A 
secondary aim was to verify the capacity of the same fruit extracts to inhibit glucose 
transport in vitro using cell culture models, and to investigate the role of SGLT1 and 
GLUT transporters in any reduction in glucose uptake observed. 
2. Materials and Methods  
2.1 Subjects 
Participants were recruited from King’s College London and the general public in the 
London area. Advertisement was done using circular emails within King’s College 
London (KCL), social networking website, poster advertising at KCL, community 
centers, and via an online advertising agency. The intended sample size of 26 
subjects had 80% power to detect a difference between average mean area under 
the curve values (0-30 min) of 0.35 mmol/L·h between test drinks with a significance 
level of α=0.01 (two-tailed), calculated from a 0.44 mmol/L standard deviation of the 
difference (using data from our previous study using anthocyanin-rich blackcurrant 
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extract) [27]. A participant information sheet was provided to volunteers who 
expressed interest; respondents were initially interviewed over the telephone. 
Inclusion criteria were: healthy men aged 20-60 y and post-menopausal women 
aged 45-60 y, BMI 18-35 kg/m2, able to understand the information sheet and willing 
to comply with study protocol and able to give informed written consent. Women 
aged 45 y or older who reported not having had a period for 12 months or longer 
were defined as postmenopausal.  Exclusion criteria were: phenylketonuria, food 
intolerances, allergies or hypersensitivity, participation in another clinical trial, 
donation of more than 1500 ml blood in the previous 12 months, full blood counts 
and liver function test results outside of the normal range, current smokers, or 
reported giving up smoking within the last 6 months, history of substance abuse or 
alcoholism, reported history of CVD, diabetes (or fasting glucose ≥ 7.1 mmol/L), 
cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely 
to alter gastrointestinal function, unwilling to restrict consumption of specified high 
polyphenol foods for 24 h before the study, weight loss >3kg in preceding 2 months 
and body mass index <18 or >35 kg/m2, blood pressure ≥160/100 mmHg, total 
cholesterol ≥ 7.5 mmol/L, fasting triacylglycerol concentrations ≥ 5.0 mmol/L, current 
use of medications that may interfere with the study such as alpha-glucosidase 
inhibitors (acarbose), insulin-sensitizing drugs (metformin), sulfonylureas, and lipid-
lowering drugs, current used of nutritional supplements that may interfere with the 
study such as higher dose vitamins/minerals (>200 % reference nutrient intake, B 
vitamins, vitamin C, calcium, copper, chromium, iodine, iron, magnesium, 
manganese, phosphorus, potassium and zinc). Eligible participants were invited to a 
screening visit in the Metabolic Research Unit at the Diabetes & Nutritional Sciences 
Division, King’s College London in a fasting state for measurement of height, weight, 
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waist circumference, % body fat (TanitaTM Body Composition Analyzer), supine blood 
pressure and digital volume pulse, liver function tests, hematology, plasma glucose 
and lipid profile. Subjects who meet all inclusion and exclusion criteria were 
randomized according to the randomization schedule created using Research 
Randomizer software (https://www.randomizer.org). The allocation of treatment was 
blinded from the investigators, laboratory technicians and the study participants by 
an external research technician. The blinding could only be broken in an emergency 
where it was essential to know which treatment a subject received in order to give 
the appropriate medical care. Investigators, laboratory technicians and participants 
remained blinded until after the study was completed and data analysis was 
performed.  
2.2 Study design  
A randomized, controlled, double-blind, cross over design was used to allow subjects 
to receive each of the 3 test drinks in random order at 3 separate study visits with at 
least 7 days wash-out between each visit. The study took 7 months to run, from 
January to July 2015, was sponsored by King’s College London and received 
approval from King’s College London ethics committee (REC reference: BDM/14/15-
10). This study abided by the principles outlined in the Declaration of Helsinki of 
1975 as revised in 1983, and registered at ClinicalTrials.gov (NCT02340039). Drinks 
were formulated by the authors and standardized to contain 0 mg polyphenols 
(CON), 1200 mg apple polyphenols (AE) and 600 mg apple polyphenols + 600 mg 
blackcurrant anthocyanins (AE+BE). Highly purified extracts instead of whole fruits 
were used in test drinks so to avoid the confounding effect of fruit fiber on gastric 
emptying rate. The liquid blackcurrant extract (BerryPharma® by Iprona AG, Lana, 
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Italy) contained 1.8 % anthocyanins (3.6 % total polyphenols). The powdered apple 
extract (Appl’InTM by DIANA Food SAS, Antrain, France) contained 67 % total 
polyphenols as analyzed by DIANA Food SAS and confirmed by the Folin-Ciocalteu 
method in the laboratory at King’s College London [28]. Of total apple polyphenols, 
40 % were flavonoid monomers and phenolic acids (40 % flavan-3-ols, 36 % 
dihydrochalcones, 13 % flavonols and 11 % hydroxycinnamic acids). The extracts 
were dispersed in a very low-polyphenol double concentrate apple and blackcurrant 
squash (Robinson’s, United Kingdom) made up with water, and drinks were matched 
for macronutrient and energy content. Each test drink consisted of a fruit drink 
providing 220 kJ, 0.2 g protein and 12 g carbohydrate, see Table 1. Test drinks (200 
ml) were dispensed into identical black bottles and labeled with codes by an external 
research technician; study investigators and participants were blind to the nature of 
the contents in each bottle. Drinks were consumed within 2 minutes immediately 
followed by consumption of the standardized high-carbohydrate meal consisting of 
100 g of white bread (Hovis, London, UK) spread with 30 g of a low-polyphenol 
apricot jam (Hartley’s, Hain Daniels Group, Leeds, UK); both high-carbohydrate 
foods are low in polyphenols (<6 mg/100 g fresh weight) [29], providing 1284 kJ and 
63 g carbohydrate; 41 g starch and 22 g as sugars. Drink and meal were consumed 
within 5 min; total carbohydrate provided including the drink was 75 g.  
On the day previous to each study visit, participants were told not to participate in 
strenuous exercise and to avoid alcohol, caffeine, oily fish, high-polyphenol and high-
nitrate foods (from a list provided), and high-fat foods. Participants were asked to 
consume a low-fat meal the evening before each visit and arrive following a 12 h 
fast, avoiding eating or drinking anything except for water until the morning of the 
study visit. Detailed dietary and lifestyle guidance was provided to each participant 
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before commencing the study period. On arrival to study days, participants were 
weighed and rested in the supine position for 10 min. Digital volume pulse (DVP) and 
blood pressure (BP) measurements were recorded for triplicate. For blood sampling 
a venous cannula was inserted in a vein in the antecubital fossa or a forearm vein by 
a trained phlebotomist, and baseline samples for analysis of glucose, insulin, C-
peptide, triacylglycerol (TAG), NEFA and GIP were collected. Glucose baseline 
samples were taken in duplicate (at -10 and -5 min). After baseline measurements 
and blood sampling participants consumed the drink immediately before the high-
carbohydrate meal. Blood samples were taken at 10, 20, 30, 45, 60, 75, 90 and 120 
minutes following the first mouthful of the high-carbohydrate meal. BP and DVP 
measurements were taken again at 60, 90 and 120 min.  
2.3 Digital volume pulse and blood pressure measurements  
Arterial tone was measured using the digital volume pulse (DVP). DVP 
measurements were obtained by photoplethysmography (PulseTrace PCA 2, Micro 
Medical Ltd, Kent, UK) and used to calculate stiffness index (DVP-SI, m/s) and 
reflection index (DVP-RI, %). DVP was measured using an infra-red probe clipped 
on the finger/thumb of any hand (preferably index finger of the non-dependent hand). 
Participants were allowed to rest quietly, in supine position, at a comfortable room 
temperature for 10 min before measurements were performed. The measurements 
were done 3 times, using the equipment default settings, separated by 30-45 
seconds. The three values for DVP-SI were within 10-15% of each other. If one was 
clearly irregular it was discarded. Blood pressure was measured at the brachial 
artery using a calibrated automated blood pressure monitor (Omron 705IT, Omron 
Healthcare Europe B.V.) immediately after DVP measurements were taken.  
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2.4 Blood sample analysis    
Blood samples were collected into fluoride/oxalate tubes (BD Vacutainer Cat no. 
368921) for glucose analysis, into SSTTM serum tubes (BD Vacutainer Cat no. 
367954) for insulin, C-peptide, TAG and NEFA analysis and into K2EDTA tubes for 
GIP analysis (BD Vacutainer Cat no. 367839). Samples were centrifuged at 1300 g, 
4 ° C for 15 min and plasma/serum aliquots were kept frozen at -40 or -80 ° C until 
biochemical analysis. Glucose, TAG and NEFA concentrations were analyzed on the 
ILab 650 chemistry analyzer using enzymatic assays (ILTM Test Cat No. 
0018259140, ILTM Triglycerides, Cat No 0018258740 and NEFA Randox Cat. No. FA 
115). ELISAs were used to analyze insulin, C-peptide (Siemens Healthcare 
Diagnostics Ltd, Frimley, Surrey, UK) and GIP concentrations (Millipore Corporation 
MA., USA). 
2.5 In vitro studies 
Cells were exposed to the same apple extract used in the dietary intervention trial at 
concentrations in the physiological range estimated to be present in the small 
intestine after ingestion of test drinks in human studies, in addition to higher and 
lower concentrations (concentration range 0.07 – 4.0 mg total polyphenols/ml). 
2.5.1 Caco-2 cells 
The human intestinal Caco-2 cell line (TC7 subclone) was cultured as previously 
described [14]. Cells were cultured at 37   °C in a humidified incubator (BIOHIT, 
HealthCare, UK) in a 5% CO2-95% air atmosphere in high-D-glucose (25 mM) with 
glutamine Dulbecco’s modified Eagle’s medium (DMEM, Sigma-Aldrich), containing 
10% fetal bovine serum (Sigma-Aldrich), 50 units penicillin and 50 µg streptomycin 
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(Sigma-Aldrich), 0.1 mM MEM non-essential amino acids (Life Technologies), 
additional 2 mM L-Glutamine (Life Technologies) and 5 µg/ml Plasmocin 
(InvivoGen). For glucose transport assays using Caco-2 monolayers, Krebs buffer 
solution (KBS) containing 30 mM HEPES (Sigma Aldrich), 130 mM NaCl, 4 mM 
KH2PO4, 1 mM MgSO4·7H20, 1 mM CaCl2, dH2O, and adjusted pH 7.4, was used as 
wash media; for sodium-free conditions NaCl was replaced with KCl. Sodium-
containing and sodium-free KBS supplemented with 0.2% bovine serum albumin 
(Sigma Aldrich) was used as pre-incubation and uptake media. Uptake media 
contained 10 mM D-glucose (BDH Laboratory Supplies) or 10 mM L-glucose (Santa 
Cruz Biotechnology) and 0.1 μCi/ml Glucose D-[14C(U)] or 0.1 μCi/ml Glucose L-[1-
14C] (Perkin Elmer) as tracer. Times for pre-incubation and uptake in all experiments 
were 15 and 10 minutes, respectively. Phlorizin, a specific competitive inhibitor of 
SGLT1 was purchased from Cayman Chemical Company. Phloretin, a specific 
inhibitor of GLUT2 (which is primarily functional at the apical membrane in the 
presence of high luminal glucose concentrations) and cytochalasin B, a GLUT1-4 
inhibitor were purchased from Santa Cruz Biotechnology. For experiments, cells 
were seeded at 8000 cell/cm2 density in 24-well plates and cultured for 21 d; cells 
were used between passages 45-53 in all experiments. Assessment of total glucose 
uptake (the sum of SGLT1- and GLUT-mediated transport) was undertaken in KBS, 
whereas quantification of GLUT-mediated uptake was undertaken in sodium-free 
KBS.  Before uptake started, DMEM was removed and cells were washed once with 
room temperature KBS. Cells were pre-incubated for 15 min with pre-incubation 
media; uptake was initiated by replacing pre-incubation media with uptake media. 
Uptake media contained, except for controls, glucose transporter inhibitors (phlorizin, 
phloretin or cytochalasin B) or increasing concentrations of the same apple and 
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blackcurrant extracts used in the clinical trial at physiological concentrations. After 10 
min the uptake media was aspirated and the transport process was stopped by 
washing each well 3 times with ice cold KBS, cells were then processed for 
radioactivity count on a Liquid Scintillation Counter (Beckman Coulter, Inc. LS6500).  
2.5.2 Oocytes 
Batches of Xenopus laevis oocytes were provided by the European Xenopus 
Resource Centre of the University of Portsmouth. Isolated oocytes were injected with 
cRNA as previously described [15]. Isolated oocytes of stage V/VI were injected 
(Nanoject II injector, Drummond Scientific Company) with 36.8 nL of rSGLT1 cRNA 
(1.2-1.5 μg/ml). Oocytes were kept at 19 °C in Modified Barth’s saline (MBS) media 
(88 mM NaCl, 1 mM KCl, 0.82 mM MgSO4, 0.33 mM Ca(NO3)2, 10 mM HEPES, 0.41 
mM CaCl2, 100U/100μg penicillin/streptomycin, 0.05 mg/L tetracycline and 0.1 mg/ml 
gentamicin, pH 7.5), checked daily and removed into fresh media when necessary. 
Transport assays were carried out 4 days post-injection, allowing time for the cRNA 
translation and expression of mature protein (SGLT1 transporter) into the oocyte 
plasma membrane. Non-injected oocytes were used as shams in the uptake assays 
and uptake was adjusted for sham diffusional glucose uptake. For glucose transport 
assays, uptake media contained 10 mM D-glucose and 0.5 μCi/ml Glucose D-
[14C(U)] as tracer. MBS media was used as uptake media and phosphate-buffered 
saline (PBS, Severn Biotech) as wash media; uptake period in all experiments was 
10 minutes. To ensure the oocyte system was functioning as expected, phlorizin and 
phloretin were tested to examine the effects of apple and blackcurrant extracts on 
glucose uptake, uptake media was added containing, except for control, increasing 
concentrations of apple and blackcurrant extracts at physiological doses. Uptake 
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was initiated by aspirating incubation media and adding 500 μL of uptake medium 
and terminated by aspirating uptake media and washing three times with 4 ml of ice 
cold PBS. Subsequently each oocyte was processed for radioactivity counting.  
2.6 Statistical analysis 
AUC and iAUC were calculated using the trapezoidal rule. iAUC was calculated by 
subtracting baseline values from all subsequent time-point values [30]. Statistical 
analysis was performed using Statistical Package for the Social Sciences (SPSS) 
v.21. Natural logarithmic transformation was used where data were not normally 
distributed. Two-way repeated measures analysis of variance (ANOVA) were used 
for treatment and treatment x time interactions, iAUC 0-30 min, iAUC 0-120 min and 
Cmax. A non-parametric Friedman’s test was used to detect a significant difference 
in Tmax between treatments. P-values were adjusted using two-way repeated 
measures ANOVA with post hoc analysis by Tukey’s adjustment for treatment and 
treatment x time interactions (GraphPad Prism). In vitro data were analyzed using 
the software GraphPad Prism 6 for Windows (GraphPad software, CA, USA). 
Experiments with normally distributed data were analyzed by one-way analysis of 
variance with Dunnett’s multiple comparison post hoc test or by unpaired t-test. 
IC50’s for cell experiments were estimated by non-linear regression analysis using 
the software SigmaPlot 13 for windows (Systat Software Inc. CA, USA). 
3. Results 
A total of 42 healthy men and postmenopausal women aged 20 to 60 years attended 
screening sessions, 34 met all inclusion criteria and were randomized to treatment. 
Twenty-five subjects completed the study. Details of study stages from enrolment to 
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completion are shown on the consort diagram (Figure 1). Baseline characteristics of 
the 25 participants who completed the study are shown in Table 2.   
3.1 Human study 
3.1.1 Glucose, insulin, C-peptide and GIP 
AE+BE and AE treatments significantly lowered plasma glucose concentrations in 
the early postprandial period (0-30 min) compared with CON (iAUC 0-30 min, see 
Table 3 for details). Post hoc analysis with Tukey’s adjustment showed significantly 
lower glucose concentrations following AE and AE+BE compared with CON at 10, 20 
and 30 min post-drink (Figure 2). Changes from baseline for glucose concentrations 
0-120 min also differed significantly by treatment; iAUC 0-120 min was significantly 
different between AE+BE and CON treatments, but not between AE and CON (Table 
3). AE and AE+BE had a lowering effect on maximal plasma glucose concentration 
(Cmax) when compared with CON: mean difference in Cmax AE vs CON (95% CI) -
0.7 (-1.3, -0.1), P<0.05; mean difference AE+BE vs CON (95% CI) -0.9 (-1.6, -0.3), 
P=0.002. Tmax was greater following AE+BE and AE (medians 60 min, IQR 45, 75, 
and 45 min, IQR 38,60 respectively) compared with CON (median 30 min, IQR 20, 
30, P<0.0001). 
AE+BE and AE treatments significantly lowered insulin and C-peptide concentrations 
compared with CON (iAUC 0-30 min, see Table 3 for details). Post hoc analysis with 
Tukey’s adjustment for multiple comparisons showed significantly lower (Ln)insulin 
and C-peptide concentrations following AE and AE+BE compared with CON at 10, 
20, 30 and 45 min post-drink, and AE vs CON for insulin at 120 min (Figure 3A) and 
AE+BE vs CON for C-peptide at 60 min (Figure 3B). Change from baseline of 
(Ln)insulin and (Ln)C-peptide concentrations 0-120 min also differed significantly by 
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treatment; iAUC 0-120 min was significantly different between treatments when 
comparing AE+BE and AE with CON for insulin and AE+BE only compared with 
CON for C-peptide (Table 3). AE+BE had a lowering effect on maximal plasma 
(Ln)insulin concentration (Cmax) when compared with CON: Cmax mean difference 
AE+BE vs CON (95% CI) -16.8 (-33.5, -0.11), P<0.05. There were no differences in 
Cmax for C-peptide between drinks. Tmax was significantly longer following 
polyphenol-rich drinks compared with CON for both insulin and C-peptide. Insulin 
Tmax was greater following AE+BE and AE (medians 75 min, IQR 60, 75, and 60 
min, IQR 45, 75 respectively) compared with CON (median 45 min, IQR 25, 60, 
P<0.0001). C-peptide Tmax was greater following AE+BE and AE (medians 75 min, 
IQR 60, 90, and 75 min, IQR 60,105, respectively) compared with CON (median 60 
min, IQR 45, 75, P<0.0001). 
AE+BE and AE treatments significantly lower GIP concentrations compared with 
CON (iAUC 0-30 min, see Table 3 for details). Post hoc analysis with Tukey’s 
adjustment for multiple comparisons showed significantly lower GIP concentrations 
following AE and AE+BE compared with CON at all timepoints up to 75 min (Figure 
4). Change from baseline of (Ln)GIP concentrations 0-120 min also differed 
significantly by treatment; iAUC 0-120 min was significantly different between 
AE+BE, AE and CON. There was a significant decrease in Cmax following AE+BE 
and AE compared with CON (mean differences (95% CI) -45.5 ng/L  (-73.6, -17.5), 
P<0.005, and -32.7 ng/L (-54.1, -11.4), P<0.01, respectively). Tmax was greater 
following AE+BE and AE (medians 90 min, IQR 83, 120, and 90 min, IQR 75,120, 
respectively) compared with CON (median 60 min, IQR 45, 75, P<0.0001). 
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3.1.2 NEFA and TAG 
AE+BE inhibited the decreases in plasma NEFA concentrations throughout the 120 
min of postprandial period; iAUC 0-120 min was significantly different between 
AE+BE and CON, mean difference (95% CI) 17.2 mmol/L.min (7.2, 27.3), P<0.005. 
Post hoc analysis with Tukey’s adjustment for multiple comparisons showed 
significantly higher NEFA concentrations following AE and AE+BE compared with 
CON from 20 min up to 120 min (Figure 5). There was a significant increase in 
Cmax following AE+BE vs CON (mean difference (95% CI) -0.14 mmol/L (-0.23, -
0.05), P<0.005). There were no significant differences in Tmax. There were no 
differences between treatments for plasma TAG concentrations (Supplementary 
Figure 1).  
3.1.3 Blood pressure and vascular function  
There were no differences between treatments for systolic and diastolic blood 
pressure (Supplementary Figure 2). There were no differences in raw data for 
stiffness and reflection index values, however change from baseline on DVP-RI 
values were significantly reduced during the whole postprandial period by treatment 
AE compared with CON (Supplementary Figure 3). 
3.2 In vitro studies 
3.2.1 Caco-2 cells 
Dose-response assays in the presence of different concentrations of apple 
polyphenols showed an inhibition on total and GLUT-mediated glucose uptake down 
to a concentration of 0.15 mg polyphenols/ml (P<0.0001) (Figure 6A and 6B). A 
concentration of 0.3 mg polyphenols/ml inhibited 51% of total glucose uptake and 
46% of sodium-independent uptake, and corresponded to an estimated effective 
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physiological dose in the human study of 600 mg apple polyphenols (900 mg apple 
extract). Similar dose-response inhibitory effects of blackcurrant extract on total and 
sodium-independent glucose uptake were observed, down to a concentration of 0.2 
mg polyphenols/ml (P<0.0001) (Figure 7A and 7B). Concentrations of blackcurrant 
polyphenols necessary to inhibit total and sodium-independent glucose uptake by 
half relative to control (0 mg polyphenols) were estimated (IC50). Blackcurrant 
polyphenols under sodium-dependent conditions (total glucose uptake) had an IC50 
of 0.51 ± 0.07 mg polyphenols/ml (mean ± SE) and under sodium-independent 
conditions an IC50 of 0.63 ± 0.07 mg polyphenols/ml, suggesting a slightly greater 
inhibition of total glucose uptake compared with GLUT-mediated glucose uptake.  
 
3.2.2 Oocytes 
In oocytes injected to express SGLT1, glucose uptake was inhibited by 85% and 
59% by phlorizin and phloretin (0.5 mM), respectively, relative to control treatment 
(P<0.0001) (data not shown). There was a highly significant relative reduction in 
glucose uptake after 0.125-4.0 mg apple polyphenols/ml (Figure 6C) and 0.1-1.6 mg 
blackcurrant polyphenols/ml (P<0.0001) (Figure 7C), with no dose-response effect 
for apple extract and an IC50 of 0.12 mg blackcurrant polyphenols/ml following 
blackcurrant extract treatment.  
4. Discussion 
Consumption of drinks containing apple polyphenols and the combination of apple 
with blackcurrant polyphenols exerted an inhibitory effect on postprandial glycemia 
and insulinemia, particularly during the first 30 min post-meal, with the combination 
of both extracts having a more potent effect. A similar response was found for the 
gut incretin, GIP, following both treatments. Previously we reported that a drink 
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containing 600 mg of blackcurrant anthocyanins inhibited plasma glucose and insulin 
early response 0-30 min. By combining the same dose with 600 mg of apple 
polyphenols in a test drink, this inhibitory effect can be increased further. The apple 
extract used in the current study was rich in phlorizin (8.4% of the extract), giving a 
total of 151 and 76 mg in the AE and AE+BE drinks, respectively. In previous 
reports, a cloudy apple juice containing 26 mg of phlorizin, 25 g glucose and 30.7 g 
fructose significantly lowered plasma glucose in human volunteers compared with a 
control drink, as demonstrated by a lower glucose iAUC 0-30 and 30-90 min [23]. 
Furthermore, a dose of 2.8 g of an apple extract containing 448 mg of phlorizin, 
reduced plasma glucose iAUC 0-45 min in healthy human subjects following a 75 g 
glucose load [8], and 25 g of unripe apple extract, derived from apple pomace, 
containing 315 mg of phlorizin reduced postprandial glucose response in healthy 
volunteers following a 50 g glucose load [24]. The magnitude of the inhibition found 
in the present study is greater than that previously reported in the literature. Possible 
explanations include the solid state of the high-carbohydrate meal prolonging 
digestion (thereby allowing more time for inhibition to take effect) compared with 
liquid meals, and the use of a mixed carbohydrate meal (starch and sucrose) as 
opposed to single carbohydrate loads of glucose, fructose, and sucrose in studies 
reported previously [8, 24].  
In vitro studies have shown inhibitory effects on the digestive enzymes, -amylase 
and -glucosidases (maltase and sucrase), by flesh and peel apple extracts [31] and 
also some of the principal individual polyphenols present in apple, such as quercetin 
[10], proanthocyanidins [32] and chlorogenic acid [33]. Furthermore,  inhibition of 
glucose transporters (SGLT1 and GLUT2) by apple extracts, phlorizin, and quercetin 
glycosides [8, 16, 34], may also contribute to the marked effect on postprandial 
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glucose and insulin response observed in vivo. Our in vitro data supports the theory 
that the apple extract in the present human study may have exerted an inhibitory 
effect on small intestinal glucose transport, since the same extract dose-dependently 
inhibited total glucose uptake and sodium-independent glucose uptake into Caco-2 
cells, a well-established in vitro model of the human enterocyte. Inhibition of glucose 
uptake in Caco-2 cells by apple extract appeared to occur predominantly via 
inhibition of the sodium-independent route, most likely mediated by GLUTs. 
However, components of the apple extract may have also inhibited the sodium-
dependent route, since the extract significantly inhibited glucose uptake into oocytes 
injected to express SGLT1. Although phlorizin is an effective inhibitor of SGLT1-
mediated glucose transport, other polyphenols contained in apple extract also have 
inhibitory effects [8] and it is likely that larger inhibitory effects on glucose uptake 
may be exerted by complex mixtures of polyphenols in fruit extracts due to additive 
or synergistic effects. Proanthocyanidins, estimated to constitute 540 and 600 mg of 
the AE+BE and AE drinks, respectively [29], are probably responsible for a 
significant proportion of the inhibitory effects on postprandial glucose response [35]. 
In vitro enzymatic studies have suggested non-specific inhibition of α-amylase by 
proanthocyanidins [7]. Interactions between polyphenols might show an additive 
effect when proanthocyanidins are combined with other phenolic compounds which 
inhibit α-amylase, such as anthocyanins [36], flavonols and flavones [37], or a 
synergistic effect when combined with α-glucosidase inhibitors such as chlorogenic 
acid [38].  
Plasma insulin concentrations follow the glycemic response curve, but circulating 
concentrations are subject to the rate of hepatic extraction as well as pancreatic 
secretion rates. We analyzed C-peptide concentrations (a polypeptide removed from 
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the proinsulin molecule to produce insulin), as a more accurate biomarker of insulin 
secretion rates [39]. Results confirm a potent inhibition of insulin secretion up to 45 
min post-meal by AE+BE, and to a lesser extent AE. Plasma NEFA concentrations 
followed the expected insulin-mediated suppression following a high-carbohydrate 
meal following each of the test drinks, but the degree of suppression was 
ameliorated following AE and AE+BE treatments compared with CON, mirroring the 
reduction in plasma insulin and GIP secretion.   
Inhibition of incretin secretion is a prime mechanistic candidate for the inhibition in 
early-phase insulin secretion. Plasma concentrations of the incretin, GIP, were 
decreased by treatments AE+BE and to a lesser extent AE up to 75 min 
postprandially, in agreement with previous findings following a drink containing 
blackcurrant extract [40]. Intestinal sodium-dependent glucose transporter SGLT1 
has been shown to be physically and physiologically related with the expression of 
GIP, and SGLT1 may act as a glucose sensor for GLP-1 secretion [41]. GIP is 
secreted in the proximal section of the small intestine by K-cells only minutes after 
carbohydrate and fat intake [42]. Our results agree with a previous report of inhibition 
of glucose-induced, SGLT1-mediated incretin secretion by phlorizin in mice [43], 
although experiments using a rat model suggest GLUT2 might also play a role as 
glucose sensor for glucose-induced incretin secretion [44]. This presents an 
additional mechanism whereby polyphenols such as phloretin, a GLUT2 inhibitor, 
may influence gut hormone secretion. Although phloretin was only present in low 
amounts in this apple extract, phlorizin could be rapidly cleaved by the enzyme 
lactase phlorizin hydrolase (LPH) to release the aglycone phloretin.      
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High dietary glycemic index and glycemic load independently increase risk of T2D 
[45]. Frequent elevated excursions in postprandial glucose concentrations are 
thought to increase risk of T2D and CVD by inducing oxidative stress and glycation 
of proteins [5]. Studies with acarbose (an inhibitor of α-glucosidase) show that 
reducing the rate of carbohydrate digestion can be as effective as metformin (an 
insulin-sensitizing drug) in reducing glycosylated hemoglobin [46], and that acarbose 
therapy can also reduce the risk of progression to diabetes in participants with 
impaired glucose tolerance by 25% [47]. The preventative effects of pharmacological 
therapies that inhibit the rate of carbohydrate digestion and absorption suggests that 
mechanistically analogous dietary strategies to control postprandial hyperglycemia 
could strengthen efforts to reduce the risk of T2D.   
Strengths of this study include the robust study design and the use of highly purified 
fruit extracts removing the confounding factor of fruit fiber. The dose of blackcurrant 
extract used is achievable in everyday diets, as intake of 600 mg of blackcurrant 
anthocyanins is equivalent to ~100 g of fresh blackcurrants [29]. In treatment 
AE+BE, the blackcurrant extract was combined with apple extract containing 600 mg 
apple phenolics. An intake of 600 mg apple phenolics is equivalent to ~300 g of fresh 
whole dessert apples (1.5-2 average (182 g) medium-sized apples [29, 48]), and the 
AE treatment was equivalent to twice this amount, which is physically possible to 
consume but unusual in single sittings. However, in this case, the apple extract was 
particularly concentrated in phlorizin; for example, the AE treatment provided an 
amount equivalent to approximately 31 medium-sized unpeeled dessert apples [29]. 
Phlorizin is present in more concentrated amounts in apple stem (pedicel), seeds 
and skin (exocarp), which are often disposed of before eating. AE+BE contained a 
higher amount of total phenolic content than AE, but half as much phlorizin. Due to 
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the diverse complexity in function-structural properties of polyphenols it is arguable 
that the different doses of total phenolics is not a hindrance to interpretation of the 
results. The combination of fruit extracts, and the potential presence of un-identified 
polyphenols contained within them, makes it difficult to attribute effects on glucose 
homeostasis entirely or even partially to specific phenolic acids or flavonoids, 
However, combinations of polyphenol-rich fruit extracts may exert potent effects on 
glucose absorption that may be additive or even synergistic in nature    
5. Conclusions  
In conclusion, ingestion of a large dose of apple polyphenol-rich extract, and half of 
this dose in combination with blackcurrant anthocyanin-rich extract, decreased 
postprandial glycemia following a starch- and sucrose-containing meal and inhibited 
secretion of insulin and an incretin (GIP). A mixture of apple and blackcurrant 
polyphenols had a more potent effect than apple polyphenols alone. Equivalent 
intakes of apple polyphenols, to the doses used in our study are challenging to 
achieve by consumption of fresh fruit, nevertheless, since apples are consumed 
frequently in the general population and are extensively available, the cumulative 
impact of daily small inhibitory effects on postprandial glycemia could potentially 
have an impact on long-term health. Although availability of blackcurrants is more 
limited, other berries more widely consumed, like strawberries, grapes, raspberries, 
blackberries, blueberries, and cranberries, contain varying profiles of anthocyanins 
and proanthocyanidins that are likely to exert similar effects. These results provide 
evidence for one of many routes by which cardio-metabolic protection may occur if 
dietary guidelines for fruit and vegetable intakes are adhered to, particularly if 
combinations are consumed shortly before, or possibly in combination with, high-
carbohydrate meals.  
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Table 1 Energy, nutrient and polyphenol composition of the test drinks 
Per 200 ml  AE AE + BE CON 
Energy and nutrients    
Energy (kJ)  222 227 219 
Carbohydrate (g)  12.2 12.2 12.1 
Starch (g)  - - - 
Sugars (g)  12.2 12.2 12.1 
of which sucrose (g)  6 6 6 
Fat (g)  - - - 
Protein (g)  0.1 0.2 - 
Fiber (g) 0.1 0.4 - 
Soluble fiber (g)  0.1 - - 
Polyphenols    
Total phenolics (mg) 1 1200 1800 <5 
Flavonoid monomers (mg)    
Flavan-3-ols (mg) 2,3  293 147 N 
Flavonols (mg) 2,3  92 46 N 
Quercetin (mg) 2,3 23 12 N 
Dihydrochalcones (mg) 2,3   263 131 N 
Phlorizin (mg) 2,3   151 76 N 
Anthocyanins (mg) 3,4   - 600 <2.5 
Phenolic acids (mg)     
Hydroxycinnamic acids (mg) 2,3 79 40 N 
Chlorogenic acid (mg) 2,3 47 23 N 
Other polyphenols (mg)1  473 964 N 
AE, 1200 mg of apple polyphenols (1800 mg apple dried extract); AE+BE, 600 mg of blackcurrant 
anthocyanins (33.3 g blackcurrant liquid extract) + 600 mg apple polyphenols (900 mg apple dried 
extract); CON, 0 mg of BE or AE. N; neglible amounts.   
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1 
Estimated from analysis of raw extract by Folin-Ciocalteu assay, not direct analysis of the drinks; 
2
 
Analysed in AE by HPLC-UV; 
3 
Estimated from Phenol-Explorer and USDA databases for apple and 
blackcurrant juices from concentrate; 
4
 Analysed in BE by spectrophotometry. 
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Table 2 Baseline characteristics of the study population (n=25) 
Variable1  
Age (y) 32.3 (14.4) 
Males 26.1 (7.5) 
Females 57.2 (3.4) 
Sex (male to female ratio) 20:5 
Body Mass Index (kg/m2) 23.5 (2.8) 
Systolic blood pressure (mmHg) 112.2 (10.8) 
Diastolic blood pressure (mmHg) 69.2 (7.9) 
Waist circumference (cm)  
Males 81.9 (7.4) 
Females 85.8 (11.4) 
Body fat (%)  
Males 16.4 (5.8) 
Females 34.9 (5.5) 
Fasting plasma glucose (mmol/L) 5.1 (0.3) 
Fasting plasma triacylglycerol (mmol/L) 1.1 (0.9) 
Fasting plasma total cholesterol (mmol/L)  4.3 (1.0) 
Fasting plasma LDL cholesterol (mmol/L) 2.6 (0.9) 
Fasting plasma HDL cholesterol (mmol/L)  
Males 1.3 (0.3) 
Females 1.6 (0.4) 
1
Values are means (SD) 
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Table 3 Effects of apple, apple and blackcurrant and placebo test drinks in incremental area under the curve (iAUC) 0-30 and 10-
120 min for plasma glucose, insulin, C-peptide and GIP in the study population (n=25)  
  
iAUC 
(0-30 min) 
 iAUC 
(0-120 min) 
 
 
Treatment 
comparison 
Mean 
difference 
95% CI1 P -value1 
Mean 
difference 
95% CI1 P value1 
Glucose  
(mmol/L·min) 
AE – CON -26.3 -34.9, -17.7 <0.0005 -29.8 -78.1, 18.4 0.363 
AE+BE – CON -31.5 -40.8, -22.2 <0.0005 -51.6 -93.8, -9.4 0.014 
AE+BE – AE -5.2 -9.8, -0.6 0.023 -21.7 -65.9, 22.5 0.638 
Insulin  
(mU/L·min) 
AE – CON  -613.1 -771.6, -454.6 0.000 -872.7 -1734.4, -11.1 0.047 
AE+BE – CON -675.3 -915.1, -435.5 0.000 -1109.7 -1642.2, -577.2 0.000 
AE+BE – AE  -62.2 -203.0, 78.6 0.782 -236.9 -1083.1, 609.2 0.565 
C-peptide  AE – CON  -9221.9 -11031.5, -7142.3 0.000 -14219.7 -31227.2, 2787.8 0.122 
  (pmol/L·min) AE+BE – CON -11881.4 -15099.3, -8663.6 0.000 -27941.8 -44418.5, 11465.1 0.001 
 AE+BE – AE  -2659.5 -4817.5, -501.6 0.013 -13722.1 -31931.5, 4487.3 0.188 
GIP  
(ng/L·min) 
AE – CON  -1272.7 -1568.3, -977.2 0.000 -4038.1 -5467.5, -2608.8 0.000 
AE+BE – CON -1735.3 -1998.1, -1472.6 0.000 -6097.2 -7742.5, -4451.9 0.000 
AE+BE – AE  -462.6 -617.2, -307.9 0.000 -2059.0 -3151.2, -966.9 0.001 
AE; 1200 mg of apple polyphenols, AE+BE; 600 mg of apple polyphenols + 600 mg blackcurrant anthocyanins, CON; 0 mg of blackcurrant anthocyanins and 
apple polyphenols. 
1
 From two-way analysis of variance, confidence interval and P-value adjusted by Bonferroni’s procedure for multiple comparisons against a reference group 
(CON), n=25. 
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Figure legends 
Figure 1 CONSORT flow diagram of the study participants 
Figure 2 Postprandial glucose concentrations  
Mean (±SEM) plasma glucose concentrations following ingestion of two test (AE, 
AE+BE) and the control (CON) drinks before consuming a mixed carbohydrate meal, 
in randomized order (n=25). AE; 1200 mg of apple polyphenols, AE+BE; 600 mg of 
apple polyphenols + 600 mg blackcurrant anthocyanins, CON; 0 mg of blackcurrant 
anthocyanins and apple polyphenols. There was an overall treatment effect on 
changes from baseline (P<0.005). Post hoc analysis of time-point differences in 
change from baseline in glucose with Tukey’s adjustment: aP<0.05 CON compared 
with AE and AE+BE; bP<0.0001 CON compared with AE and AE+BE; cP<0.001 AE 
compared with AE+BE and CON; dP<0.05 AE compared with AE+BE; eP<0.05 CON 
compared with AE. 
Figure 3 Postprandial insulin and C-peptide concentrations  
Mean (±SEM) plasma insulin (A) and C-peptide (B) concentrations following 
ingestion of two test (AE, AE+BE) and the control (CON) drinks before consuming a 
mixed carbohydrate meal, in randomized order (n=25). AE; 1200 mg of apple 
polyphenols, AE+BE; 600 mg of apple polyphenols + 600 mg blackcurrant 
anthocyanins, CON; 0 mg of blackcurrant anthocyanins and apple polyphenols. (A) 
There was an overall treatment effect on changes from baseline (P<0.001). Post hoc 
analysis of time-point differences in change from baseline in insulin compared with 
Tukey’s adjustment: aP < 0.0001 CON compared with AE and AE+BE; bP<0.005 AE 
compared with AE+BE; cP<0.0001 CON compared with AE+BE; dP<0.05 CON 
compared with AE. (B) There was an overall treatment effect on changes from 
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baseline (P<0.0001). Post hoc analysis of time-point differences in change from 
baseline in C-peptide with Tukey’s adjustment: aP<0.0001 CON compared with AE 
and AE+BE; bP<0.05 AE compared with AE+BE; cP<0.0001 AE compared with 
AE+BE; dP<0.0005 AE compared with AE+BE; eP<0.005 CON compared with 
AE+BE; fP<0.05 AE compared with AE+BE. 
Figure 4 Postprandial GIP concentrations 
Mean (±SEM) plasma GIP concentrations following ingestion of 3 low sugar fruit 
drinks immediately before consuming a mixed carbohydrate meal, in randomized 
order (n=25). AE; 1200 mg of apple polyphenols, AE+BE; 600 mg of apple 
polyphenols + 600 mg blackcurrant anthocyanins, CON; 0 mg of blackcurrant 
anthocyanins and apple polyphenols. There was an overall treatment effect on 
changes from baseline (P<0.0001). Post hoc analysis of time-point differences in 
change from baseline with Tukey’s adjustment: aP<0.0001 CON compared with AE 
and AE+BE; bP<0.05 AE compared with AE+BE; cP<0.0001 AE compared with 
AE+BE; dP<0.0001 CON compared with AE+BE; eP<0.05 CON compared with AE; 
fP<0.05 CON compared with AE+BE.  
Figure 5 Postprandial non-esterified fatty acid concentrations  
Mean (±SEM) plasma NEFA concentrations following ingestion of 3 low sugar fruit 
drinks immediately before consuming a mixed carbohydrate meal, in randomized 
order (n=25). Baseline values (mmol/L): AE 0.47±0.05, AE+BE 0.40±0.04, CON 
0.54±0.04. AE; 1200 mg of apple polyphenols, AE+BE; 600 mg of apple polyphenols 
+ 600 mg blackcurrant anthocyanins, CON; 0 mg of blackcurrant anthocyanins and 
apple polyphenols. There was an overall treatment effect on changes from baseline 
(P<0.001). Post hoc analysis of time-point differences in change from baseline in 
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NEFA with Tukey’s adjustment: aP<0.0005 CON compared with AE+BE; bP<0.05 
CON compared with AE; cP<0.0001 CON compared with AE and AE+BE; dP<0.05 
AE compared with AE+BE; eP<0.0001 CON compared with AE+BE; fP<0.0005 CON 
compared with AE; gP<0.005 AE compared with AE+BE. 
Figure 6 Acute effects of apple extract on total and GLUT-mediated glucose 
transport in Caco-2 cells (A and B), and SGLT-mediated glucose uptake in 
Xenopus oocytes (C) 
Caco-2/TC7 cells and Xenopus oocytes injected to express SGLT1 were treated with 
increasing concentrations of apple polyphenols contained in uptake media. Values 
were corrected for simple diffusion by subtracting L-glucose uptake in the case of 
Caco-2 cells, and corrected for diffusional glucose uptake in oocytes by subtracting 
sham oocytes uptake. Data are presented as mean ± SEM (n=3-5). One-way 
analysis of variance followed by multiple comparisons against control with Dunnett’s 
adjustment: (A) Total glucose uptake in Caco-2/TC7 cells: ****P<0.0001 for the 
difference between control and 0.15, 0.3, 0.5, 1.0 and 2.0 mg apple polyphenols/ml 
treatments. (B) GLUT-mediated glucose uptake in Caco-2/TC7 cells: ***P<0.0005 for 
the difference between control and 0.15, 0.3 and 0.5 mg apple polyphenols/ml 
treatments.(C) SGLT-mediated uptake in oocytes: ****P<0.0001 for the difference 
between 0 mg/ml and 0.125, 0.25, 0.5, 1.0, 2.0 and 4.0 mg apple polyphenols/ml.  
Figure 7 Acute dose response effects of blackcurrant extract on total and 
GLUT-mediated glucose transport in Caco-2 cells (A and B), and SGLT-
mediated glucose uptake in Xenopus oocytes (C)  
Caco-2/TC7 cells and Xenopus oocytes injected to express SGLT1 were treated with 
increasing concentrations of blackcurrant polyphenols contained in uptake media. 
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Values were corrected for simple diffusion by subtracting L-glucose uptake in the 
case of Caco-2 cells, and corrected for diffusional glucose uptake in oocytes by 
subtracting sham oocytes uptake. Data are presented as mean ± SEM (n=3-5). One-
way analysis of variance followed by multiple comparisons against control with 
Dunnett’s adjustment: (A) Total glucose uptake in Caco-2/TC7 cells: ***P<0.001 for 
the difference between control and 0.2 mg blackcurrant polyphenols/ml; 
****P<0.0001 for the difference between control and 0.4, 0.8, 1.6 and 3.2 mg 
blackcurrant polyphenols/ml treatments. (B) GLUT-mediated uptake conditions in 
Caco-2 cells: ****P<0.0001 for the difference between control and 0.2, 0.4, 0.8 and 
1.6 mg blackcurrant polyphenols/ml treatments. (C) SGLT-mediated uptake in 
oocytes: ****P<0.0001 for the difference between 0 mg/ml and 0.1, 0.2, 0.4, 0.8, and 
1.6 mg blackcurrant polyphenols/ml. Nonlinear regression analysis was used to 
estimate IC50 values.      
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IC50= 0.51 ± 0.07 mg/ml 
IC50= 0.63 ± 0.07 mg/ml 
IC50= 0.12 ± 0.003 mg/ml 
Figure 7 
